Statistical issues in drug development / Stephen Senn.
Saved in:
| Superior document: | Statistics in practice |
|---|---|
| : | |
| TeilnehmendeR: | |
| Year of Publication: | 2007 |
| Edition: | 2nd ed. |
| Language: | English |
| Series: | Statistics in practice.
|
| Online Access: | |
| Physical Description: | xix, 498 p. :; ill. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
500351458 |
|---|---|
| ctrlnum |
(MiAaPQ)500351458 (Au-PeEL)EBL351458 (CaPaEBR)ebr10232744 (CaONFJC)MIL130834 (OCoLC)476172339 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Senn, Stephen. Statistical issues in drug development [electronic resource] / Stephen Senn. 2nd ed. Chichester, England ; Hoboken, NJ : John Wiley & Sons, c2007. xix, 498 p. : ill. Statistics in practice Includes bibliographical references and index. A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information -- The measurement of treatment effects -- Demographic subgroups : representation and analysis -- Multiplicity -- Intention to treat, missing data and related matters -- One-sided and two-sided tests and other issues to do with significance and P-values -- Determining the sample size -- Multicentre trials -- Active control equivalence studies -- Meta-analysis -- Cross-over trials -- n-of-1 trials -- Sequential trials -- Dose-finding -- Concerning pharmacokinetics and pharmacodynamics -- Bioequivalence studies -- Safety data, harms, drug monitoring, and pharmaco-epidemiology -- Pharmaco-economics and portfolio management -- Concerning pharmacogenetics, pharmacogenomics, and related matters. Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Drug development Statistical methods. Electronic books. ProQuest (Firm) Statistics in practice. https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=351458 Click to View |
| language |
English |
| format |
Electronic eBook |
| author |
Senn, Stephen. |
| spellingShingle |
Senn, Stephen. Statistical issues in drug development Statistics in practice A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information -- The measurement of treatment effects -- Demographic subgroups : representation and analysis -- Multiplicity -- Intention to treat, missing data and related matters -- One-sided and two-sided tests and other issues to do with significance and P-values -- Determining the sample size -- Multicentre trials -- Active control equivalence studies -- Meta-analysis -- Cross-over trials -- n-of-1 trials -- Sequential trials -- Dose-finding -- Concerning pharmacokinetics and pharmacodynamics -- Bioequivalence studies -- Safety data, harms, drug monitoring, and pharmaco-epidemiology -- Pharmaco-economics and portfolio management -- Concerning pharmacogenetics, pharmacogenomics, and related matters. |
| author_facet |
Senn, Stephen. ProQuest (Firm) ProQuest (Firm) |
| author_variant |
s s ss |
| author2 |
ProQuest (Firm) |
| author2_role |
TeilnehmendeR |
| author_corporate |
ProQuest (Firm) |
| author_sort |
Senn, Stephen. |
| title |
Statistical issues in drug development |
| title_full |
Statistical issues in drug development [electronic resource] / Stephen Senn. |
| title_fullStr |
Statistical issues in drug development [electronic resource] / Stephen Senn. |
| title_full_unstemmed |
Statistical issues in drug development [electronic resource] / Stephen Senn. |
| title_auth |
Statistical issues in drug development |
| title_new |
Statistical issues in drug development |
| title_sort |
statistical issues in drug development |
| series |
Statistics in practice |
| series2 |
Statistics in practice |
| publisher |
John Wiley & Sons, |
| publishDate |
2007 |
| physical |
xix, 498 p. : ill. |
| edition |
2nd ed. |
| contents |
A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information -- The measurement of treatment effects -- Demographic subgroups : representation and analysis -- Multiplicity -- Intention to treat, missing data and related matters -- One-sided and two-sided tests and other issues to do with significance and P-values -- Determining the sample size -- Multicentre trials -- Active control equivalence studies -- Meta-analysis -- Cross-over trials -- n-of-1 trials -- Sequential trials -- Dose-finding -- Concerning pharmacokinetics and pharmacodynamics -- Bioequivalence studies -- Safety data, harms, drug monitoring, and pharmaco-epidemiology -- Pharmaco-economics and portfolio management -- Concerning pharmacogenetics, pharmacogenomics, and related matters. |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RM - Therapeutics and Pharmacology |
| callnumber-label |
RM301 |
| callnumber-sort |
RM 3301.25 S46 42007 |
| genre |
Electronic books. |
| genre_facet |
Electronic books. |
| url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=351458 |
| illustrated |
Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
615 - Pharmacology & therapeutics |
| dewey-full |
615/.190727 |
| dewey-sort |
3615 6190727 |
| dewey-raw |
615/.190727 |
| dewey-search |
615/.190727 |
| oclc_num |
476172339 |
| work_keys_str_mv |
AT sennstephen statisticalissuesindrugdevelopment AT proquestfirm statisticalissuesindrugdevelopment |
| status_str |
n |
| ids_txt_mv |
(MiAaPQ)500351458 (Au-PeEL)EBL351458 (CaPaEBR)ebr10232744 (CaONFJC)MIL130834 (OCoLC)476172339 |
| hierarchy_parent_title |
Statistics in practice |
| is_hierarchy_title |
Statistical issues in drug development |
| container_title |
Statistics in practice |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1792330684226863104 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02548nam a22004334a 4500</leader><controlfield tag="001">500351458</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">071101s2007 enka sb 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2007045553</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="z">101319993</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780470018774 (cloth : alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0470018771 (cloth : alk. paper)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)500351458</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL351458</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10232744</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL130834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)476172339</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM301.25</subfield><subfield code="b">.S46 2007</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615/.190727</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Senn, Stephen.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Statistical issues in drug development</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">Stephen Senn.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Chichester, England ;</subfield><subfield code="a">Hoboken, NJ :</subfield><subfield code="b">John Wiley & Sons,</subfield><subfield code="c">c2007.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xix, 498 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Statistics in practice</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information --</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The measurement of treatment effects -- Demographic subgroups : representation and analysis -- Multiplicity -- Intention to treat, missing data and related matters -- One-sided and two-sided tests and other issues to do with significance and P-values -- Determining the sample size -- Multicentre trials -- Active control equivalence studies --</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Meta-analysis -- Cross-over trials -- n-of-1 trials -- Sequential trials -- Dose-finding -- Concerning pharmacokinetics and pharmacodynamics -- Bioequivalence studies -- Safety data, harms, drug monitoring, and pharmaco-epidemiology -- Pharmaco-economics and portfolio management -- Concerning pharmacogenetics, pharmacogenomics, and related matters.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug development</subfield><subfield code="x">Statistical methods.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Statistics in practice.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=351458</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |